COMPANY

Chrysalis BioTherapeutics

HQ: Galveston, TX source · chrysbio.com ↗ · Southwest

Keywords: respiratory adult respiratory distress syndrome

Location: Galveston, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

14NIH grants

NIH awards 14

Annual award amounts. Total $15.0M.

2020 NIH contract (government contract; not a grant and not an investment round) 272201700011C-P00011-9999-2 FY2020: $1,500,152 awarded for that fiscal year; activity N01 (OTHER_NIH); PI SOWER, LAURIE; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTO source ↗
2019 NIH contract (government contract; not a grant and not an investment round) 272201700011C-P00008-9999-1 FY2019: $1,864,898 awarded for that fiscal year; activity N01 (OTHER_NIH); PI SOWER, LAURIE; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTO source ↗
Mar 12, 2018 NIH award 5R44AI086135-07 FY2018: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SOWER, LAURIE E; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. TP508: A New Drug for Mitigati source ↗
2018 NIH contract (government contract; not a grant and not an investment round) 272201700011C-2-0-1 FY2018: $1,984,084 awarded for that fiscal year; activity N01 (OTHER_NIH); PI SOWER, LAURIE; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. source ↗
Mar 15, 2017 NIH award 5R44AI086135-06 FY2017: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SOWER, LAURIE E; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. TP508: A New Drug for Mitigati source ↗
2017 NIH contract (government contract; not a grant and not an investment round) 272201700011C-0-0-1 FY2017: $1,605,375 awarded for that fiscal year; activity N01 (OTHER_NIH); PI SOWER, LAURIE; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. source ↗
Apr 11, 2016 NIH award 2R44AI086135-05 FY2016: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SOWER, LAURIE E; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. TP508: A New Drug for Mitigati source ↗
Jun 24, 2014 NIH award 5R44AI086135-04 FY2014: $978,663 awarded for that fiscal year; activity R44 (SBIR); PI SOWER, LAURIE E; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. TP508: A New Drug for Mitigating source ↗
Jul 3, 2013 NIH award 5R44AI086135-03 FY2013: $810,416 awarded for that fiscal year; activity R44 (SBIR); PI SOWER, LAURIE E; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. TP508: A New Drug for Mitigating source ↗
2013 NIH contract (government contract; not a grant and not an investment round) 261201300076C-0-0-1 FY2013: $1,499,927 awarded for that fiscal year; activity N44 (OTHER_NIH); PI SOWER, LAURIE; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. I source ↗
Aug 20, 2012 NIH award 2R44AI086135-02 FY2012: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI OLSZEWSKA-PAZDRAK, BARBARA MARIA; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. TP508: A New source ↗
Aug 9, 2011 NIH award 1R41AI093032-01A1 FY2011: $300,000 awarded for that fiscal year; activity R41 (STTR); PI GOLDBLUM, RANDALL M; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. Prevention of Allergic Rhi source ↗
2011 NIH contract (government contract; not a grant and not an investment round) 261201100035C-0-0-1 FY2011: $199,757 awarded for that fiscal year; activity N43 (OTHER_NIH); PI OLSZEWSKA-PAZDRAK, BARBARA; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVE source ↗
Mar 15, 2010 NIH award 1R43AI086135-01 FY2010: $297,326 awarded for that fiscal year; activity R43 (SBIR); PI OLSZEWSKA-PAZDRAK, BARBARA MARIA; recipient as written: CHRYSALIS BIOTHERAPEUTICS, INC., GALVESTON, TX. TP508:A New Dru source ↗